BHC vs. GILD
Compare and contrast key facts about Bausch Health Companies Inc. (BHC) and Gilead Sciences, Inc. (GILD).
Performance
BHC vs. GILD - Performance Comparison
Loading graphics...
BHC vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BHC Bausch Health Companies Inc. | -22.30% | -13.77% | 0.50% | 27.71% | -77.25% | 32.74% | -30.48% | 61.99% | -11.12% | 43.11% |
GILD Gilead Sciences, Inc. | 14.19% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -6.70% | 7.88% | -9.92% | 2.96% |
Fundamentals
BHC:
$0.63
GILD:
$6.79
BHC:
8.58
GILD:
20.54
BHC:
0.06
GILD:
0.05
BHC:
0.13
GILD:
5.94
BHC:
$10.16B
GILD:
$29.44B
BHC:
$10.09B
GILD:
$23.79B
BHC:
$2.78B
GILD:
$12.90B
Returns By Period
In the year-to-date period, BHC achieves a -22.30% return, which is significantly lower than GILD's 14.19% return. Over the past 10 years, BHC has underperformed GILD with an annualized return of -15.21%, while GILD has yielded a comparatively higher 7.74% annualized return.
BHC
- 1D
- 7.36%
- 1M
- -8.94%
- YTD
- -22.30%
- 6M
- -16.28%
- 1Y
- -16.54%
- 3Y*
- -12.64%
- 5Y*
- -29.82%
- 10Y*
- -15.21%
GILD
- 1D
- 2.22%
- 1M
- -5.90%
- YTD
- 14.19%
- 6M
- 27.11%
- 1Y
- 27.69%
- 3Y*
- 22.97%
- 5Y*
- 20.37%
- 10Y*
- 7.74%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BHC vs. GILD — Risk / Return Rank
BHC
GILD
BHC vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BHC | GILD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.29 | 0.96 | -1.25 |
Sortino ratioReturn per unit of downside risk | -0.07 | 1.55 | -1.62 |
Omega ratioGain probability vs. loss probability | 0.99 | 1.18 | -0.19 |
Calmar ratioReturn relative to maximum drawdown | -0.41 | 2.03 | -2.44 |
Martin ratioReturn relative to average drawdown | -0.74 | 5.55 | -6.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BHC | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.29 | 0.96 | -1.25 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.49 | 0.86 | -1.35 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.25 | 0.30 | -0.55 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | 0.39 | -0.50 |
Correlation
The correlation between BHC and GILD is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BHC vs. GILD - Dividend Comparison
BHC has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.29%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BHC Bausch Health Companies Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 2.29% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Drawdowns
BHC vs. GILD - Drawdown Comparison
The maximum BHC drawdown since its inception was -98.35%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for BHC and GILD.
Loading graphics...
Drawdown Indicators
| BHC | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.35% | -70.83% | -27.52% |
Max Drawdown (1Y)Largest decline over 1 year | -40.53% | -13.77% | -26.76% |
Max Drawdown (5Y)Largest decline over 5 years | -86.79% | -26.59% | -60.20% |
Max Drawdown (10Y)Largest decline over 10 years | -88.08% | -36.01% | -52.07% |
Current DrawdownCurrent decline from peak | -97.94% | -10.04% | -87.90% |
Average DrawdownAverage peak-to-trough decline | -60.60% | -22.20% | -38.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.52% | 5.04% | +17.48% |
Volatility
BHC vs. GILD - Volatility Comparison
Bausch Health Companies Inc. (BHC) has a higher volatility of 13.15% compared to Gilead Sciences, Inc. (GILD) at 6.41%. This indicates that BHC's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BHC | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.15% | 6.41% | +6.74% |
Volatility (6M)Calculated over the trailing 6-month period | 34.17% | 18.97% | +15.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.36% | 29.00% | +27.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.54% | 23.93% | +36.61% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.99% | 25.63% | +35.36% |
Financials
BHC vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Bausch Health Companies Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities